OUR SOLUTIONS

Machine Learning in Radiotherapy

Kancure Therapeutics is developing clinically-focused strategies to channel the advances in AI into cancer patient treatment.

Read more

 

PROTACs in Radiosensitization

Kancure is developing PROTACs that can cross blood brain barrier (BBB) to treat CNS diseases such as primary brain tumor, brain metastasis, and degenerative brain diseases.

Read more

E3 Ligases in Human Diseases

Our leading PROTACs can penetrate BBB and can target degradation of key pro-survival proteins in glioma. Also, we are developing developing platforms by designing and synthesizing new E3 ligases ligands/inhibitors.

Read more